The stronger the binding, the weaker the cancer growth [53], suggesting that Zfra4-10 or WWOX7-21 peptide-induced HYAL-2/WWOX/SMAD4 signaling is involved in the increased binding of WWOX with its partners. Here, SMAD4 is linked to cancer.